Creekwood Pharmaceuticals Llc, based in U.S.A, is a pharmaceutical company.
One of their notable products is VILOXAZINE HYDROCHLORIDE, with a corresponding US DMF Number 40706.
Remarkably, this DMF maintains an Active status since its submission on November 15, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 30, 2024, and payment made on November 14, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II